Loading…
Employees: 59
Size Raghav Productivity Enhancers (RPEL.NS) is an India Materials company (Chemicals: Major Diversified) with a market value of $864M, the 641st largest of 1,058 India companies the cockpit tracks. Shares closed at ₹1,781 on 6 Nov 2026.
Performance Over six months the shares gained 132.9%, against -24.8% for the median peer and 0.0% for the India market (cap-weighted) — highest of 21 in its peer set.
Growth Revenue grew 38.2% over the last twelve months (peer median +3.2%); the operating margin is 27.6% (peer median 10.3%).
Valuation It trades at 25.8× enterprise value to sales against a peer median of 3.5× (most expensive of 21).
Capital Return on invested capital runs 5.9 points above its cost of capital (19.9% WACC).
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|
| Revenue | ₹3.15B | ₹2.57B | ₹2.00B | ₹1.33B | ₹1.37B |
| Revenue growth | — | +29% | +50% | -3% | — |
| Gross profit | ₹2.09B | ₹1.51B | ₹1.19B | ₹759M | ₹799M |
| EBITDA | ₹940M | ₹761M | ₹545M | ₹406M | ₹362M |
| Net income | ₹705M | ₹548M | ₹370M | ₹260M | ₹252M |
| Free cash flow | n/a | ₹226M | ₹246M | ₹112M | -₹137M |
| Capital expenditure | n/a | ₹138M | ₹133M | ₹90.8M | ₹339M |
| Total debt | ₹45.8M | ₹54.1M | ₹70.8M | ₹87.4M | ₹99.9M |
The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.
Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.
| Measure | RPEL.NS | Peer median | Rank in peer set |
|---|---|---|---|
| 1-month return | -2.2% | -15.0% | 3rd highest of 21 |
| 6-month return | +132.9% | -24.8% | highest of 21 |
| Distance from 52-week high | -8.4% | -41.8% | 3rd highest of 21 |
| Revenue growth (TTM) | +38.2% | +3.2% | highest of 21 |
| Operating margin | 27.6% | 10.3% | 2nd highest of 21 |
| EV / Sales | 25.8× | 3.5× | most expensive of 21 |
| ROIC minus cost of capital | +5.9 pp | -3.0 pp | 4th highest of 21 |
| EV / EBITDA | 86.6× | 13.0× | most expensive of 9 |
| Net debt / EBITDA | -0.3× | -1.4× | 4th most indebted of 10 |
| Company | Market | Market cap | 6M return | Revenue growth | Op. margin | EV / Sales | Req g | Delivered g |
|---|---|---|---|---|---|---|---|---|
| Raghav Productivity Enhancers RPEL.NS | India | $864M | +133% | +38% | 28% | 25.8× | n/a | n/a |
| Suzhou Highfine Biotech 301393.SZ | China | $865M | -8% | +36% | 17% | 6.5× | n/a | n/a |
| Guangzhou Sanfu Newmaterials Technology 688359.SS | China | $870M | -41% | +8% | -7% | 10.7× | n/a | n/a |
| Polyrocks Chemical 688669.SS | China | $831M | +40% | -8% | -6% | 2.2× | 35.9% | +15.2% |
| Sanyo Chemical Industries 4471.T | Japan | $823M | +24% | 0% | 10% | 0.8× | -5.1% | -2.5% |
| Jiangxi Hungpai New Material 605366.SS | China | $821M | -47% | +2% | -11% | 3.8× | n/a | n/a |
| Zhejiang Huangma Technology 603181.SS | China | $935M | -30% | +7% | 17% | 2.4× | n/a | n/a |
| Xinyaqiang Silicon Chemistry 603155.SS | China | $788M | -6% | +6% | 10% | 5.9× | 31.1% | +3.9% |
| Hubei Chaozhuo Aviation Technology 688237.SS | China | $776M | +6% | -1% | 1% | 12.1× | 45.3% | +26.0% |
| Jubilant Ingrevia JUBLINGREA.NS | India | $966M | -24% | +15% | 10% | 2.0× | 27.3% | +44.9% |
| Daxin Materials 5234.TW | Taiwan | $767M | -42% | +10% | 19% | 5.1× | 17.7% | +1.5% |
| Jiangsu Zhengdan Chemical Industry 300641.SZ | China | $981M | -28% | -30% | 17% | 2.4× | 8.8% | +11.6% |
| JCU 4975.T | Japan | $759M | -26% | +2% | 40% | 3.2× | 6.3% | +7.0% |
| Caregen 214370.KS | South Korea | $1.01B | -73% | -8% | 24% | 17.9× | 35.2% | +3.8% |
| KH Neochem 4189.T | Japan | $732M | +20% | -11% | 12% | 1.2× | -5.7% | +8.3% |
| Victrex VCT.L | United Kingdom | $1.04B | +54% | -1% | 14% | 2.7× | 15.7% | +1.9% |
| Liaoning Oxiranchem,Inc 300082.SZ | China | $716M | -39% | +4% | 0% | 1.3× | n/a | n/a |
| Dalian Bio-Chem 603360.SS | China | $1.05B | -55% | 0% | 16% | 5.5× | 9.5% | +18.4% |
| Jiansu Huachang Chemical 002274.SZ | China | $679M | -25% | +9% | -3% | 0.7× | 23.6% | +1.3% |
| Ningxia Zhongke Biotechnology 600165.SS | China | $679M | -19% | +8% | -73% | 8.7× | n/a | n/a |
| Shandong Sanyuan Biotechnology 301206.SZ | China | $676M | -18% | +15% | 4% | 4.0× | n/a | n/a |